GB0011903D0
(en)
*
|
2000-05-18 |
2000-07-05 |
Astrazeneca Ab |
Combination chemotherapy
|
US9492400B2
(en)
*
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
US9267937B2
(en)
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
ES2776100T3
(es)
*
|
2006-03-31 |
2020-07-29 |
Massachusetts Inst Technology |
Sistema para el suministro dirigido de agentes terapéuticos
|
US20110052697A1
(en)
*
|
2006-05-17 |
2011-03-03 |
Gwangju Institute Of Science & Technology |
Aptamer-Directed Drug Delivery
|
US9381477B2
(en)
|
2006-06-23 |
2016-07-05 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
US20100144845A1
(en)
*
|
2006-08-04 |
2010-06-10 |
Massachusetts Institute Of Technology |
Oligonucleotide systems for targeted intracellular delivery
|
ES2532595T3
(es)
*
|
2006-08-30 |
2015-03-30 |
Kyushu University, National University Corporation |
Composición farmacéutica que contiene una nanopartícula de estatina encapsulada
|
US8168661B2
(en)
*
|
2006-11-06 |
2012-05-01 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
US8168662B1
(en)
|
2006-11-06 |
2012-05-01 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
US8178564B2
(en)
*
|
2006-11-06 |
2012-05-15 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
US8173686B2
(en)
|
2006-11-06 |
2012-05-08 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
US20100303723A1
(en)
*
|
2006-11-20 |
2010-12-02 |
Massachusetts Institute Of Technology |
Drug delivery systems using fc fragments
|
US20110033528A1
(en)
*
|
2009-08-05 |
2011-02-10 |
Poniard Pharmaceuticals, Inc. |
Stabilized picoplatin oral dosage form
|
US9217129B2
(en)
|
2007-02-09 |
2015-12-22 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
WO2008124632A1
(en)
*
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Amphiphilic compound assisted nanoparticles for targeted delivery
|
CN101784192B
(zh)
|
2007-06-26 |
2015-03-18 |
约翰·霍普金斯大学 |
标记的前列腺特异性膜抗原(psma)的抑制子、生物学评估及作为成像试剂的用途
|
US20100260832A1
(en)
*
|
2007-06-27 |
2010-10-14 |
Poniard Pharmaceuticals, Inc. |
Combination therapy for ovarian cancer
|
TW200916094A
(en)
*
|
2007-06-27 |
2009-04-16 |
Poniard Pharmaceuticals Inc |
Stabilized picoplatin dosage form
|
EP2178893A4
(en)
*
|
2007-07-16 |
2012-09-19 |
Poniard Pharmaceuticals Inc |
ORAL FORMULATIONS FOR PICOPLATIN
|
EP3858347A3
(en)
|
2007-08-17 |
2021-12-01 |
Purdue Research Foundation |
Psma binding ligand-linker conjugates and methods for using
|
HUE035101T2
(hu)
|
2007-09-28 |
2018-05-02 |
Pfizer |
Ráksejtek célzása nanorészecskék alkalmazásával
|
AU2008314647B2
(en)
|
2007-10-12 |
2013-03-21 |
Massachusetts Institute Of Technology |
Vaccine nanotechnology
|
US9422234B2
(en)
*
|
2007-11-30 |
2016-08-23 |
The Johns Hopkins University |
Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer
|
AU2009210654A1
(en)
*
|
2008-02-08 |
2009-08-13 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin and bevacizumab to treat colorectal cancer
|
US8034396B2
(en)
*
|
2008-04-01 |
2011-10-11 |
Tyco Healthcare Group Lp |
Bioadhesive composition formed using click chemistry
|
WO2009134769A1
(en)
*
|
2008-04-28 |
2009-11-05 |
Novartis Ag |
Nanoparticles for use in pharmaceutical compositions
|
WO2010005726A2
(en)
|
2008-06-16 |
2010-01-14 |
Bind Biosciences Inc. |
Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
|
PT2774608T
(pt)
|
2008-06-16 |
2020-01-17 |
Pfizer |
Nanopartículas poliméricas carregadas com fármaco e métodos de produção e utilização das mesmas
|
EA020753B1
(ru)
|
2008-06-16 |
2015-01-30 |
Бинд Терапьютикс, Инк. |
Терапевтические полимерные наночастицы, содержащие алкалоиды vinca, и их применение
|
CA2987744C
(en)
|
2008-08-01 |
2022-11-15 |
The Johns Hopkins University |
Psma-binding agents and uses thereof
|
WO2010027428A1
(en)
|
2008-08-26 |
2010-03-11 |
Massachusetts Institute Of Technology |
Platinum ( iv) complexes for use in dual mode pharmaceutical therapy
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8603532B2
(en)
|
2008-10-20 |
2013-12-10 |
Massachusetts Institute Of Technology |
Nanostructures for drug delivery
|
US8846096B2
(en)
*
|
2008-12-12 |
2014-09-30 |
Creighton University |
Nanoparticles and methods of use
|
WO2010068866A2
(en)
*
|
2008-12-12 |
2010-06-17 |
Bind Biosciences |
Therapeutic particles suitable for parenteral administration and methods of making and using same
|
JP2012512175A
(ja)
*
|
2008-12-15 |
2012-05-31 |
バインド バイオサイエンシズ インコーポレイテッド |
治療薬を徐放するための長時間循環性ナノ粒子
|
EP2210584A1
(en)
*
|
2009-01-27 |
2010-07-28 |
Bayer Schering Pharma Aktiengesellschaft |
Stable polymeric composition comprising an epothilone and an amphiphilic block copolymer
|
AU2010215931A1
(en)
|
2009-02-21 |
2011-10-13 |
Covidien Lp |
Medical devices having activated surfaces
|
AU2010215194A1
(en)
|
2009-02-21 |
2011-10-13 |
Sofradim Production |
Apparatus and method of reacting polymers passing through metal ion chelated resin matrix to produce injectable medical devices
|
US9273191B2
(en)
|
2009-02-21 |
2016-03-01 |
Sofradim Production |
Medical devices with an activated coating
|
US8535477B2
(en)
|
2009-02-21 |
2013-09-17 |
Sofradim Production |
Medical devices incorporating functional adhesives
|
US8968733B2
(en)
*
|
2009-02-21 |
2015-03-03 |
Sofradim Production |
Functionalized surgical adhesives
|
US8512728B2
(en)
|
2009-02-21 |
2013-08-20 |
Sofradim Production |
Method of forming a medical device on biological tissue
|
WO2010095053A2
(en)
|
2009-02-21 |
2010-08-26 |
Sofradim Production |
Apparatus and method of reaching polymers by exposure to uv radiation to produce injectable medical devices
|
US8663689B2
(en)
*
|
2009-02-21 |
2014-03-04 |
Sofradim Production |
Functionalized adhesive medical gel
|
US8877170B2
(en)
*
|
2009-02-21 |
2014-11-04 |
Sofradim Production |
Medical device with inflammatory response-reducing coating
|
WO2010095045A1
(en)
|
2009-02-21 |
2010-08-26 |
Sofradim Production |
Amphiphilic compounds and self-assembling compositions made therefrom
|
US8969473B2
(en)
|
2009-02-21 |
2015-03-03 |
Sofradim Production |
Compounds and medical devices activated with solvophobic linkers
|
EP2398943B1
(en)
|
2009-02-21 |
2013-04-17 |
Sofradim Production |
Crosslinked fibers and method of making same using uv radiation
|
AU2010215196B2
(en)
|
2009-02-21 |
2015-04-16 |
Covidien Lp |
Crosslinked fibers and method of making same by extrusion
|
AU2010215936B2
(en)
|
2009-02-21 |
2015-03-05 |
Covidien Lp |
Medical devices having activated surfaces
|
WO2010114770A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
EP2413901A4
(en)
*
|
2009-03-30 |
2015-05-06 |
Cerulean Pharma Inc |
POLYMER CONCRETE CONJUGATES, PARTICLES, COMPOSITIONS AND CORRESPONDING USES
|
WO2010114768A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-epothilone conjugates, particles, compositions, and related methods of use
|
CN101536982B
(zh)
*
|
2009-04-27 |
2011-11-09 |
中国人民解放军第二军医大学 |
Trastuzumab修饰的包裹毒素蛋白的PEG化免疫脂质体及其制备与应用
|
WO2011005363A2
(en)
*
|
2009-05-18 |
2011-01-13 |
Ensysce Biosciences, Inc. |
Carbon nanotubes complexed with multiple bioactive agents and methods related thereto
|
US9937128B2
(en)
|
2009-08-03 |
2018-04-10 |
The University Of North Carolina At Chapel Hill |
Liposomes comprising a calcium phosphate-containing precipitate
|
CN102782573A
(zh)
*
|
2009-11-22 |
2012-11-14 |
圣诺制药公司 |
在治疗和诊断中应用的稀土掺杂上转换纳米颗粒
|
US8357401B2
(en)
|
2009-12-11 |
2013-01-22 |
Bind Biosciences, Inc. |
Stable formulations for lyophilizing therapeutic particles
|
US9295649B2
(en)
|
2009-12-15 |
2016-03-29 |
Bind Therapeutics, Inc. |
Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
|
EP2512487A4
(en)
*
|
2009-12-15 |
2013-08-07 |
|
THERAPEUTIC POLYMERNANOPARTICLES WITH CORTICOSTEROIDS AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
EP2512459A4
(en)
*
|
2009-12-15 |
2013-08-07 |
|
THERAPEUTIC POLYMERIC NANOPARTICLES COMPRISING EPOTHILONE AND METHODS OF MAKING AND USING SAME
|
US9951324B2
(en)
|
2010-02-25 |
2018-04-24 |
Purdue Research Foundation |
PSMA binding ligand-linker conjugates and methods for using
|
EP2550031B1
(en)
|
2010-03-25 |
2015-08-19 |
Sofradim Production |
Medical devices incorporating functional adhesives
|
US9272074B2
(en)
*
|
2010-03-25 |
2016-03-01 |
Sofradim Production |
Surgical fasteners and methods for sealing wounds
|
WO2011133617A1
(en)
*
|
2010-04-23 |
2011-10-27 |
The Board Of Trustees Of The University Of Illinois |
Nano-hybrid delivery system for sequential utilization of passive and active targeting
|
CA2799468A1
(en)
|
2010-05-14 |
2011-11-17 |
Mallinckrodt Llc |
Functional, cross-linked nanostructures for tandem optical imaging and therapy
|
US9247931B2
(en)
|
2010-06-29 |
2016-02-02 |
Covidien Lp |
Microwave-powered reactor and method for in situ forming implants
|
CA2804251A1
(en)
|
2010-07-01 |
2012-01-05 |
Sofradim Production |
Medical device with predefined activated cellular integration
|
AU2011284449B2
(en)
|
2010-07-27 |
2015-07-23 |
Sofradim Production |
Polymeric fibers having tissue reactive members
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
US9549901B2
(en)
|
2010-09-03 |
2017-01-24 |
The Brigham And Women's Hospital, Inc. |
Lipid-polymer hybrid particles
|
CN104531812A
(zh)
|
2010-10-01 |
2015-04-22 |
现代治疗公司 |
设计核酸及其使用方法
|
US20150056300A1
(en)
*
|
2010-10-22 |
2015-02-26 |
Bind Therapeutics, Inc. |
Therapeutic nanoparticles with high molecular weight copolymers
|
WO2012059936A1
(en)
|
2010-11-03 |
2012-05-10 |
Padma Venkitachalam Devarajan |
Pharmaceutical compositions for colloidal drug delivery
|
CA2819240C
(en)
|
2010-12-02 |
2021-06-15 |
Ecosynthetix Ltd. |
Aptamer bioconjugate drug delivery device
|
US10363309B2
(en)
|
2011-02-04 |
2019-07-30 |
Case Western Reserve University |
Targeted nanoparticle conjugates
|
WO2012135805A2
(en)
|
2011-03-31 |
2012-10-04 |
modeRNA Therapeutics |
Delivery and formulation of engineered nucleic acids
|
US20140308363A1
(en)
*
|
2011-05-31 |
2014-10-16 |
Bind Therapeutics, Inc. |
Drug loaded polymeric nanoparticles and methods of making and using same
|
MX2013015340A
(es)
|
2011-06-21 |
2014-05-28 |
Brigham & Womens Hospital |
Composiciones y metodos para el tratamiento de cancer.
|
US9605304B2
(en)
*
|
2011-07-20 |
2017-03-28 |
The Hong Kong Polytechnic University |
Ultra-stable oligonucleotide-gold and-silver nanoparticle conjugates and method of their preparation
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
EP2747761A1
(en)
*
|
2011-09-22 |
2014-07-02 |
Bind Therapeutics, Inc. |
Methods of treating cancers with therapeutic nanoparticles
|
RU2707251C2
(ru)
|
2011-10-03 |
2019-11-25 |
Модерна Терапьютикс, Инк. |
Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение
|
WO2013059634A1
(en)
|
2011-10-20 |
2013-04-25 |
The Regents Of The University Of California |
Use of cdk9 inhibitors to reduce cartilage degradation
|
US9006199B2
(en)
*
|
2011-11-14 |
2015-04-14 |
Silenseed Ltd. |
Methods and compositions for treating prostate cancer
|
KR20140102759A
(ko)
|
2011-12-16 |
2014-08-22 |
모더나 세라퓨틱스, 인코포레이티드 |
변형된 뉴클레오사이드, 뉴클레오타이드 및 핵산 조성물
|
WO2013151666A2
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of biologics and proteins associated with human disease
|
US9878056B2
(en)
|
2012-04-02 |
2018-01-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
EP2833892A4
(en)
|
2012-04-02 |
2016-07-20 |
Moderna Therapeutics Inc |
MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS AND PEPTIDES ASSOCIATED WITH ONCOLOGY
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
US9107904B2
(en)
|
2012-04-05 |
2015-08-18 |
Massachusetts Institute Of Technology |
Immunostimulatory compositions and methods of use thereof
|
WO2013163176A1
(en)
|
2012-04-23 |
2013-10-31 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
US8729286B2
(en)
|
2012-05-10 |
2014-05-20 |
Massachusetts Institute Of Technology |
Platinum compounds as treatment for cancers, and related methods, kits, and compositions
|
CA2790763A1
(en)
*
|
2012-05-31 |
2013-11-30 |
Ecosynthetix Ltd. |
Aptamer bioconjugate drug delivery device
|
CN112587671A
(zh)
|
2012-07-18 |
2021-04-02 |
博笛生物科技有限公司 |
癌症的靶向免疫治疗
|
CN104736181A
(zh)
|
2012-08-10 |
2015-06-24 |
北德克萨斯大学健康科学中心 |
包含靶向聚氨基酸与脂肪酸之缀合物的药物递送载剂
|
JP2014051478A
(ja)
*
|
2012-09-10 |
2014-03-20 |
Panasonic Corp |
機能性物質、生体活性用薬剤及び機能性物質の生体内への浸透方法、並びに機能性物質放散装置及び空気清浄装置
|
MX356097B
(es)
|
2012-09-17 |
2018-05-14 |
Pfizer Inc Star |
Proceso para la preparacion de nanoparticulas terapeuticas.
|
US9931410B2
(en)
*
|
2012-10-09 |
2018-04-03 |
The Brigham And Women's Hospital, Inc. |
Nanoparticles for targeted delivery of multiple therapeutic agents and methods of use
|
US9801953B2
(en)
|
2012-10-15 |
2017-10-31 |
Emory University |
Nanoparticles carrying nucleic acid cassettes for expressing RNA
|
US9180203B2
(en)
*
|
2012-10-23 |
2015-11-10 |
The Johns Hopkins University |
Self-assembling drug amphiphiles and methods for synthesis and use
|
MX2015006109A
(es)
*
|
2012-11-15 |
2016-02-05 |
Endocyte Inc |
Conjugados para el tratamiento de enfermedades causadas por celulas que expresan psma.
|
JP6144355B2
(ja)
|
2012-11-26 |
2017-06-07 |
モデルナティエックス インコーポレイテッドModernaTX,Inc. |
化学修飾mRNA
|
EP2938364A1
(en)
*
|
2012-12-28 |
2015-11-04 |
Blend Therapeutics, Inc. |
Targeted conjugates encapsulated in particles and formulations thereof
|
US10342846B2
(en)
|
2013-02-04 |
2019-07-09 |
University Of Notre Dame Du Lac |
Nanoparticle drug delivery systems
|
WO2014127365A1
(en)
*
|
2013-02-15 |
2014-08-21 |
Case Western Reserve University |
Psma ligands and uses thereof
|
US10207005B2
(en)
|
2013-02-15 |
2019-02-19 |
Case Western Reserve University |
Photodynamic therapy composition
|
US11975074B2
(en)
|
2013-02-15 |
2024-05-07 |
Case Western Reserve University |
Photodynamic therapy composition
|
WO2014131376A1
(en)
*
|
2013-02-26 |
2014-09-04 |
Elmarco S.R.O. |
Electrospun nanofibers comprising pharmaceutically active agents
|
US9133225B2
(en)
|
2013-03-13 |
2015-09-15 |
Massachusetts Institute Of Technology |
Dual targeting anticancer agents
|
BR112015021979A2
(pt)
|
2013-03-14 |
2017-08-29 |
Regeneron Pharma |
Anticorpos humanos para grem1
|
WO2014152211A1
(en)
|
2013-03-14 |
2014-09-25 |
Moderna Therapeutics, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
AU2014248090B2
(en)
*
|
2013-04-03 |
2018-08-02 |
N-Fold Llc |
Novel nanoparticle compositions
|
WO2014165782A2
(en)
|
2013-04-05 |
2014-10-09 |
Massachusetts Institute Of Technology |
Compositions, methods, and kits comprising platinum compounds associated with a ligand comprising a targeting moiety
|
US20140356414A1
(en)
*
|
2013-06-03 |
2014-12-04 |
University Of Southern California |
Targeted Crosslinked Multilamellar Liposomes
|
US9775928B2
(en)
|
2013-06-18 |
2017-10-03 |
Covidien Lp |
Adhesive barbed filament
|
US10434194B2
(en)
|
2013-06-20 |
2019-10-08 |
Case Western Reserve University |
PSMA targeted nanobubbles for diagnostic and therapeutic applications
|
US9657094B2
(en)
*
|
2013-06-24 |
2017-05-23 |
Colorado School Of Mines |
Biodegradable polymers for delivery of therapeutic agents
|
EP3971287A1
(en)
|
2013-07-11 |
2022-03-23 |
ModernaTX, Inc. |
Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use
|
AU2014315287A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
US20160194368A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
US10323076B2
(en)
|
2013-10-03 |
2019-06-18 |
Modernatx, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
RS65324B1
(sr)
|
2013-10-18 |
2024-04-30 |
Novartis Ag |
Obeleženi inhibitori membranskog antigena specifičnog za prostatu (psma), njihova upotreba kao agenasa za snimanje i farmaceutskih agenasa za lečenje karcinoma prostate
|
US10542918B2
(en)
|
2013-10-23 |
2020-01-28 |
Verily Life Sciences Llc |
Modulation of a response signal to distinguish between analyte and background signals
|
US9636034B2
(en)
|
2013-10-23 |
2017-05-02 |
Verily Life Sciences Llc |
Non-invasive analyte detection system with modulation source
|
WO2015070210A1
(en)
|
2013-11-11 |
2015-05-14 |
Wake Forest University Health Sciences |
Epha3 and multi-valent targeting of tumors
|
WO2015073678A1
(en)
*
|
2013-11-14 |
2015-05-21 |
Endocyte, Inc. |
Compounds for positron emission tomography
|
KR102507624B1
(ko)
|
2013-11-22 |
2023-03-09 |
미나 테라퓨틱스 리미티드 |
C/ebp 알파 짧은 활성화 rna 조성물 및 사용 방법
|
US20160303242A1
(en)
|
2013-12-09 |
2016-10-20 |
Durect Corporation |
Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
|
CA2933579A1
(en)
|
2013-12-11 |
2015-06-18 |
University Of Massachusetts |
Compositions and methods for treating disease using salmonella t3ss effector protein (sipa)
|
JP2017500865A
(ja)
|
2013-12-19 |
2017-01-12 |
ノバルティス アーゲー |
レプチンmRNAの組成物および製剤
|
AU2015205753A1
(en)
|
2014-01-10 |
2016-07-21 |
Birdie Biopharmaceuticals Inc. |
Compounds and compositions for treating HER2 positive tumors
|
WO2015120476A1
(en)
*
|
2014-02-10 |
2015-08-13 |
Salk Institute For Biological Studies |
Increasing storage of vitamin a, vitamin d and/or lipids
|
PL3116547T3
(pl)
|
2014-03-14 |
2019-11-29 |
Pfizer |
Terapeutyczne nanocząstki zawierające środek terapeutyczny i sposoby ich wytwarzania i zastosowania
|
CN103861112B
(zh)
*
|
2014-03-25 |
2015-12-30 |
国家纳米科学中心 |
基于聚合物纳米粒子载体的药物组合物及其制备方法
|
US10138331B2
(en)
*
|
2014-04-24 |
2018-11-27 |
Rensselaer Polytechnic Institute |
Matrix-free polymer nanocomposites and related products and methods thereof
|
RU2771104C2
(ru)
|
2014-05-14 |
2022-04-26 |
Таргиммьюн Терапьютикс Аг |
Улучшенные полиэтилениминовые полиэтиленгликолевые векторы
|
ES2834556T3
(es)
|
2014-06-25 |
2021-06-17 |
Acuitas Therapeutics Inc |
Lípidos y formulaciones de nanopartículas lipídicas novedosos para la entrega de ácidos nucleicos
|
CN112546231A
(zh)
|
2014-07-09 |
2021-03-26 |
博笛生物科技有限公司 |
用于治疗癌症的联合治疗组合物和联合治疗方法
|
CA2954446A1
(en)
|
2014-07-09 |
2016-01-14 |
Shanghai Birdie Biotech, Inc. |
Anti-pd-l1 combinations for treating tumors
|
CA2955250A1
(en)
|
2014-07-16 |
2016-01-21 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
US20170210788A1
(en)
|
2014-07-23 |
2017-07-27 |
Modernatx, Inc. |
Modified polynucleotides for the production of intrabodies
|
CN112546238A
(zh)
|
2014-09-01 |
2021-03-26 |
博笛生物科技有限公司 |
用于治疗肿瘤的抗-pd-l1结合物
|
CN104306332B
(zh)
*
|
2014-09-24 |
2017-02-15 |
东南大学 |
一种喜树碱类磷脂化合物、其药物组合物及应用
|
US9968688B2
(en)
|
2014-11-12 |
2018-05-15 |
Verily Life Sciences Llc |
Shielded targeting agents, methods, and in vivo diagnostic system
|
EP3220900B1
(en)
|
2014-11-21 |
2020-09-23 |
University of Maryland, Baltimore |
Targeted structure-specific particulate delivery systems
|
US11045428B2
(en)
|
2014-11-21 |
2021-06-29 |
University Of Maryland, Baltimore |
Decreased adhesivity receptor-targeted nanoparticles for Fn14-positive tumors
|
US10188759B2
(en)
|
2015-01-07 |
2019-01-29 |
Endocyte, Inc. |
Conjugates for imaging
|
US9861710B1
(en)
|
2015-01-16 |
2018-01-09 |
Verily Life Sciences Llc |
Composite particles, methods, and in vivo diagnostic system
|
US10758520B1
(en)
|
2015-05-20 |
2020-09-01 |
University Of South Florida |
Glutathione-coated nanoparticles for delivery of MKT-077 across the blood-brain barrier
|
JP2018516982A
(ja)
|
2015-05-31 |
2018-06-28 |
キュアジェニックス コーポレーション |
免疫療法用併用剤組成物
|
JP7072386B2
(ja)
|
2015-06-29 |
2022-05-20 |
アクイタス セラピューティクス インコーポレイテッド |
核酸の送達のための脂質および脂質ナノ粒子製剤
|
CA2993823C
(en)
|
2015-07-28 |
2024-01-02 |
Board Of Regents, The University Of Texas System |
Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
|
HRP20220156T1
(hr)
|
2015-09-17 |
2022-04-15 |
Modernatx, Inc. |
Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
|
WO2017053720A1
(en)
*
|
2015-09-25 |
2017-03-30 |
Tarveda Therapeutics, Inc. |
RNAi CONJUGATES, PARTICLES AND FORMULATIONS THEREOF
|
BR112018005899A2
(pt)
|
2015-09-30 |
2018-10-16 |
Deutsches Krebsforschungszentrum |
composto e composição farmacêutica
|
US20170128592A1
(en)
*
|
2015-10-01 |
2017-05-11 |
Indian Institute Of Technology, Bombay |
Targeted polymeric nano-complexes as drug delivery system
|
MA47016A
(fr)
|
2015-10-22 |
2018-08-29 |
Modernatx Inc |
Vaccins contre les virus respiratoires
|
BR112018008090A2
(pt)
|
2015-10-22 |
2018-11-13 |
Modernatx Inc |
vacina de vírus do herpes simplex.
|
EP3365008A4
(en)
|
2015-10-22 |
2019-08-07 |
ModernaTX, Inc. |
VACCINE AGAINST RESPIRATORY SYNZYTIAL VIRUS
|
JP7384512B2
(ja)
|
2015-10-22 |
2023-11-21 |
モデルナティエックス インコーポレイテッド |
広域インフルエンザウイルスワクチン
|
TW201729838A
(zh)
|
2015-10-22 |
2017-09-01 |
現代公司 |
用於水痘帶狀疱疹病毒 (vzv)之核酸疫苗
|
JP6921833B2
(ja)
|
2015-10-22 |
2021-08-18 |
モデルナティーエックス, インコーポレイテッド |
ヒトサイトメガロウイルスワクチン
|
CN108368028B
(zh)
|
2015-10-28 |
2021-09-03 |
爱康泰生治疗公司 |
用于递送核酸的新型脂质和脂质纳米颗粒制剂
|
US20180271998A1
(en)
|
2015-12-04 |
2018-09-27 |
Merrimack Pharmaceuticals, Inc. |
Disulfide-stabilized fabs
|
DK3394030T3
(da)
|
2015-12-22 |
2022-03-28 |
Modernatx Inc |
Forbindelser og sammensætninger til intracellulær afgivelse af midler
|
ES2919552T3
(es)
|
2015-12-23 |
2022-07-27 |
Modernatx Inc |
Procedimientos de utilización de polinucleotidos codificadores de ligando ox40
|
WO2017115372A1
(en)
|
2015-12-30 |
2017-07-06 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd |
Pt(IV) PRODRUGS
|
CN115350279A
(zh)
|
2016-01-07 |
2022-11-18 |
博笛生物科技有限公司 |
用于治疗肿瘤的抗-her2组合
|
CN115252792A
(zh)
|
2016-01-07 |
2022-11-01 |
博笛生物科技有限公司 |
用于治疗肿瘤的抗-egfr组合
|
CN106943596A
(zh)
|
2016-01-07 |
2017-07-14 |
博笛生物科技(北京)有限公司 |
用于治疗肿瘤的抗-cd20组合
|
EP3400023A1
(en)
|
2016-01-10 |
2018-11-14 |
ModernaTX, Inc. |
Therapeutic mrnas encoding anti ctla-4 antibodies
|
EP3416623B1
(en)
|
2016-02-15 |
2021-08-11 |
University of Georgia Research Foundation, Inc. |
Ipa-3-loaded liposomes and methods of use thereof
|
US10548881B2
(en)
|
2016-02-23 |
2020-02-04 |
Tarveda Therapeutics, Inc. |
HSP90 targeted conjugates and particles and formulations thereof
|
JP2019513756A
(ja)
*
|
2016-04-08 |
2019-05-30 |
ザ クリーブランド クリニック ファウンデーションThe Cleveland ClinicFoundation |
骨疾患を治療するための薬物送達用ナノ粒子
|
US10940112B2
(en)
|
2016-05-04 |
2021-03-09 |
L.E.A.F. Holdings Group Llc |
Targeted liposomal gemcitabine compositions and methods thereof
|
JP6757061B2
(ja)
*
|
2016-05-09 |
2020-09-16 |
東京都公立大学法人 |
ドラッグデリバリー用脂質単層被覆型ナノ粒子
|
US10300145B2
(en)
|
2016-07-15 |
2019-05-28 |
Massachusetts Institute Of Technology |
Synthetic nanoparticles for delivery of immunomodulatory compounds
|
CN106176595B
(zh)
*
|
2016-08-31 |
2019-10-22 |
辰欣药业股份有限公司 |
一种更昔洛韦注射液及其制备工艺
|
US11583504B2
(en)
|
2016-11-08 |
2023-02-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
TW202311284A
(zh)
|
2017-01-03 |
2023-03-16 |
美商再生元醫藥公司 |
抗金黃色葡萄球菌溶血素a毒素之人類抗體
|
AU2018234814B2
(en)
|
2017-03-15 |
2022-06-30 |
Modernatx, Inc. |
Crystal forms of amino lipids
|
KR20190132405A
(ko)
|
2017-03-15 |
2019-11-27 |
모더나티엑스, 인크. |
치료제의 세포내 전달을 위한 화합물 및 조성물
|
AU2018234828A1
(en)
|
2017-03-15 |
2019-09-19 |
Modernatx, Inc. |
Lipid nanoparticle formulation
|
EP3600371A4
(en)
*
|
2017-03-21 |
2021-06-09 |
The Regents of The University of Michigan |
AGAINST ERG THERAPY
|
US10369230B2
(en)
|
2017-04-06 |
2019-08-06 |
National Guard Health Affairs |
Sustained release of a therapeutic agent from PLA-PEG-PLA nanoparticles for cancer therapy
|
CN108794467A
(zh)
|
2017-04-27 |
2018-11-13 |
博笛生物科技有限公司 |
2-氨基-喹啉衍生物
|
IL301115A
(en)
|
2017-04-28 |
2023-05-01 |
Acuitas Therapeutics Inc |
New lipid carbonyl and lipid nanoparticle formulations for delivery of nucleic acids
|
WO2018213789A1
(en)
|
2017-05-18 |
2018-11-22 |
Modernatx, Inc. |
Modified messenger rna comprising functional rna elements
|
CA3063723A1
(en)
|
2017-05-18 |
2018-11-22 |
Modernatx, Inc. |
Polynucleotides encoding tethered interleukin-12 (il12) polypeptides and uses thereof
|
US20200268666A1
(en)
|
2017-06-14 |
2020-08-27 |
Modernatx, Inc. |
Polynucleotides encoding coagulation factor viii
|
MA49421A
(fr)
|
2017-06-15 |
2020-04-22 |
Modernatx Inc |
Formulations d'arn
|
PL3641730T3
(pl)
*
|
2017-06-22 |
2021-08-23 |
SNBioScience Inc. |
Cząstka i kompozycja farmaceutyczna zawierająca nierozpuszczalną pochodną kamptotecyny z podwójną strukturą rdzenia i powłoki oraz sposób ich wytwarzania
|
MX2019015744A
(es)
|
2017-06-23 |
2020-02-20 |
Birdie Biopharmaceuticals Inc |
Composiciones farmaceuticas.
|
AR113097A1
(es)
|
2017-07-17 |
2020-01-29 |
Medincell |
Mezclas de composiciones biodegradables que modulan la cinética de liberación de al menos un ingrediente activo en la administración de fármacos
|
WO2019046809A1
(en)
|
2017-08-31 |
2019-03-07 |
Modernatx, Inc. |
METHODS OF MANUFACTURING LIPID NANOPARTICLES
|
EP4219715A3
(en)
|
2017-09-08 |
2023-09-06 |
MiNA Therapeutics Limited |
Stabilized cebpa sarna compositions and methods of use
|
CA3075205A1
(en)
|
2017-09-08 |
2019-03-14 |
Mina Therapeutics Limited |
Stabilized hnf4a sarna compositions and methods of use
|
EP3470056B1
(en)
|
2017-10-16 |
2022-04-27 |
Medtronic Vascular Inc. |
Therapeutic nanoparticles for treating vascular diseases
|
RU2669937C1
(ru)
*
|
2017-10-17 |
2018-10-17 |
федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) |
Фармацевтическая противоопухолевая композиция паклитаксела с гистоном Н1.3 в качестве носителя и способ получения композиции
|
EP3714048A1
(en)
|
2017-11-22 |
2020-09-30 |
Modernatx, Inc. |
Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders
|
CA3079543A1
(en)
|
2017-11-22 |
2019-05-31 |
Modernatx, Inc. |
Polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits for the treatment of propionic acidemia
|
EP3714047A2
(en)
|
2017-11-22 |
2020-09-30 |
ModernaTX, Inc. |
Polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuria
|
WO2019136241A1
(en)
|
2018-01-05 |
2019-07-11 |
Modernatx, Inc. |
Polynucleotides encoding anti-chikungunya virus antibodies
|
AU2019234536A1
(en)
*
|
2018-03-15 |
2020-10-15 |
Atossa Therapeutics, Inc. |
In situ methods of inducing of immune response
|
WO2019183633A1
(en)
|
2018-03-23 |
2019-09-26 |
Case Western Reserve Univeristy |
Psma targeted conjugate compounds and uses thereof
|
BR112020016701A2
(pt)
|
2018-03-28 |
2020-12-15 |
Greenmark Biomedical Inc. |
Métodos para fabricar nanopartículas, para tratar dentes e para fabricar uma nanopartícula de biopolímero, nanopartículas, uso das nanopartículas, nanopartícula de amido reticulada com polifosfato, e, uso de uma nanopartícula de amido reticulada com polifosfato.
|
JP2021521100A
(ja)
*
|
2018-04-06 |
2021-08-26 |
ノース カロライナ ステート ユニバーシティNorth Carolina State University |
癌免疫療法のためのチェックポイント阻害剤の細胞集団を介した送達
|
EP3773745A1
(en)
|
2018-04-11 |
2021-02-17 |
ModernaTX, Inc. |
Messenger rna comprising functional rna elements
|
EP3775211B1
(en)
|
2018-04-12 |
2023-04-05 |
MiNA Therapeutics Limited |
Sirt1-sarna compositions and methods of use
|
KR20210021452A
(ko)
*
|
2018-04-23 |
2021-02-26 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
Cdk9 억제제의 국소 전달을 위한 지속 방출 제형
|
JP2021523151A
(ja)
|
2018-05-11 |
2021-09-02 |
ホスホレックス、インコーポレイテッド |
負の表面電荷を有するマイクロ粒子及びナノ粒子
|
WO2019226650A1
(en)
|
2018-05-23 |
2019-11-28 |
Modernatx, Inc. |
Delivery of dna
|
WO2020023390A1
(en)
|
2018-07-25 |
2020-01-30 |
Modernatx, Inc. |
Mrna based enzyme replacement therapy combined with a pharmacological chaperone for the treatment of lysosomal storage disorders
|
EP3833762A4
(en)
|
2018-08-09 |
2022-09-28 |
Verseau Therapeutics, Inc. |
OLIGONUCLEOTIDE COMPOSITIONS FOR TARGETING CCR2 AND CSF1R AND THEIR USES
|
EA201800477A1
(ru)
*
|
2018-08-28 |
2020-02-28 |
Ооо "Нпк Альфа-Онкотехнологии" |
Препарат для лечения онкологических заболеваний
|
MA53545A
(fr)
|
2018-09-02 |
2021-07-14 |
Modernatx Inc |
Polynucléotides codant pour l'acyl-coa déshydrogénase à très longue chaîne pour le traitement de l'insuffisance en acyl-coa déshydrogénase à très longue chaîne
|
JP2022500436A
(ja)
|
2018-09-13 |
2022-01-04 |
モダーナティエックス・インコーポレイテッドModernaTX, Inc. |
糖原病を処置するためのグルコース−6−ホスファターゼをコードするポリヌクレオチド
|
WO2020056155A2
(en)
|
2018-09-13 |
2020-03-19 |
Modernatx, Inc. |
Polynucleotides encoding branched-chain alpha-ketoacid dehydrogenase complex e1-alpha, e1-beta, and e2 subunits for the treatment of maple syrup urine disease
|
JP2022500444A
(ja)
|
2018-09-14 |
2022-01-04 |
モダーナティエックス・インコーポレイテッドModernaTX, Inc. |
クリグラー−ナジャー症候群の治療のためのウリジン二リン酸グリコシルトランスフェラーゼ1ファミリー、ポリペプチドa1をコードするポリヌクレオチド
|
MA53734A
(fr)
|
2018-09-27 |
2021-08-04 |
Modernatx Inc |
Polynucléotides codant pour l'arginase 1 pour le traitement d'une déficience en arginase
|
WO2020097409A2
(en)
|
2018-11-08 |
2020-05-14 |
Modernatx, Inc. |
Use of mrna encoding ox40l to treat cancer in human patients
|
KR102615834B1
(ko)
*
|
2018-12-31 |
2023-12-21 |
생-고뱅 퍼포먼스 플라스틱스 코포레이션 |
분해성 담체를 수용하는 용기
|
CN113474328A
(zh)
|
2019-01-11 |
2021-10-01 |
爱康泰生治疗公司 |
用于脂质纳米颗粒递送活性剂的脂质
|
EP3911336A4
(en)
*
|
2019-01-18 |
2023-05-10 |
Case Western Reserve University |
PSMA LIGAND-TARGETED COMPOUNDS AND USES THEREOF
|
WO2020208361A1
(en)
|
2019-04-12 |
2020-10-15 |
Mina Therapeutics Limited |
Sirt1-sarna compositions and methods of use
|
WO2020227642A1
(en)
|
2019-05-08 |
2020-11-12 |
Modernatx, Inc. |
Compositions for skin and wounds and methods of use thereof
|
MA56203A
(fr)
|
2019-06-12 |
2022-04-20 |
Regeneron Pharma |
Anticorps humains dirigés contre la protéine morphogénétique osseuse 6
|
MA56539A
(fr)
|
2019-06-24 |
2022-04-27 |
Modernatx Inc |
Arn messager résistant à l'endonucléase et utilisations correspondantes
|
MA56517A
(fr)
|
2019-06-24 |
2022-04-27 |
Modernatx Inc |
Arn messager comprenant des éléments d'arn fonctionnels et leurs utilisations
|
EP4031524A1
(en)
|
2019-09-19 |
2022-07-27 |
ModernaTX, Inc. |
Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
|
AU2020355000A1
(en)
|
2019-09-23 |
2022-03-17 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating apolipoprotein B (APOB) gene expression
|
EP4041894A1
(en)
|
2019-09-23 |
2022-08-17 |
Omega Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR MODULATING HEPATOCYTE NUCLEAR FACTOR 4-ALPHA (HNF4a) GENE EXPRESSION
|
US20230105243A1
(en)
*
|
2019-12-03 |
2023-04-06 |
Onselex Pharmaceuticals, Inc. |
Polyphosphazene drug carriers
|
WO2021183318A2
(en)
*
|
2020-03-09 |
2021-09-16 |
President And Fellows Of Harvard College |
Methods and compositions relating to improved combination therapies
|
EP4118207A1
(en)
|
2020-03-11 |
2023-01-18 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating forkhead box p3 (foxp3) gene expression
|
WO2021247507A1
(en)
|
2020-06-01 |
2021-12-09 |
Modernatx, Inc. |
Phenylalanine hydroxylase variants and uses thereof
|
AU2021289600A1
(en)
|
2020-06-12 |
2023-01-19 |
University Of Rochester |
Encoding and expression of ACE-tRNAs
|
WO2022016070A1
(en)
|
2020-07-16 |
2022-01-20 |
Acuitas Therapeutics, Inc. |
Cationic lipids for use in lipid nanoparticles
|
MX2023004101A
(es)
|
2020-10-08 |
2023-10-11 |
Targimmune Therapeutics Ag |
Inmunoterapia para el tratamiento de cancer.
|
EP4243776A1
(en)
|
2020-11-13 |
2023-09-20 |
Modernatx, Inc. |
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
|
GB2603454A
(en)
|
2020-12-09 |
2022-08-10 |
Ucl Business Ltd |
Novel therapeutics for the treatment of neurodegenerative disorders
|
WO2022150356A1
(en)
*
|
2021-01-06 |
2022-07-14 |
Florida Atlantic University Board Of Trustees |
Cancer treatment regimen using anti-parasitic compounds and gut microbiome modulating agents
|
EP4281475A1
(en)
|
2021-01-25 |
2023-11-29 |
Regeneron Pharmaceuticals, Inc. |
Anti-pdgf-b antibodies and mehods of use for treating pulmonary arterial hypertension (pah)
|
US11524023B2
(en)
|
2021-02-19 |
2022-12-13 |
Modernatx, Inc. |
Lipid nanoparticle compositions and methods of formulating the same
|
WO2022204369A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Polynucleotides encoding methylmalonyl-coa mutase for the treatment of methylmalonic acidemia
|
WO2022204380A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits and uses thereof
|
WO2022204390A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding phenylalanine hydroxylase and uses thereof
|
US20240189449A1
(en)
|
2021-03-24 |
2024-06-13 |
Modernatx, Inc. |
Lipid nanoparticles and polynucleotides encoding ornithine transcarbamylase for the treatment of ornithine transcarbamylase deficiency
|
US20240207374A1
(en)
|
2021-03-24 |
2024-06-27 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding glucose-6-phosphatase and uses thereof
|
KR20230160872A
(ko)
|
2021-03-26 |
2023-11-24 |
미나 테라퓨틱스 리미티드 |
Tmem173 sarna 조성물 및 사용 방법
|
EP4337177A1
(en)
|
2021-05-11 |
2024-03-20 |
Modernatx, Inc. |
Non-viral delivery of dna for prolonged polypeptide expression in vivo
|
EP4355882A2
(en)
|
2021-06-15 |
2024-04-24 |
Modernatx, Inc. |
Engineered polynucleotides for cell-type or microenvironment-specific expression
|
WO2022271776A1
(en)
|
2021-06-22 |
2022-12-29 |
Modernatx, Inc. |
Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndrome
|
EP4367242A2
(en)
|
2021-07-07 |
2024-05-15 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating secreted frizzled receptor protein 1 (sfrp1) gene expression
|
WO2023056044A1
(en)
|
2021-10-01 |
2023-04-06 |
Modernatx, Inc. |
Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular disease
|
WO2023059809A2
(en)
*
|
2021-10-06 |
2023-04-13 |
The Regents Of The University Of California |
Methods and agents for prevention of viral proliferation
|
WO2023079142A2
(en)
|
2021-11-05 |
2023-05-11 |
Targimmune Therapeutics Ag |
Targeted linear conjugates comprising polyethyleneimine and polyethylene glycol and polyplexes comprising the same
|
WO2023086833A1
(en)
|
2021-11-09 |
2023-05-19 |
Case Western Reserve University |
Psma targeted conjugate compounds and uses thereof
|
WO2023099884A1
(en)
|
2021-12-01 |
2023-06-08 |
Mina Therapeutics Limited |
Pax6 sarna compositions and methods of use
|
GB202117758D0
(en)
|
2021-12-09 |
2022-01-26 |
Ucl Business Ltd |
Therapeutics for the treatment of neurodegenerative disorders
|
WO2023150753A1
(en)
|
2022-02-07 |
2023-08-10 |
University Of Rochester |
Optimized sequences for enhanced trna expression or/and nonsense mutation suppression
|
WO2023161350A1
(en)
|
2022-02-24 |
2023-08-31 |
Io Biotech Aps |
Nucleotide delivery of cancer therapy
|
WO2023170435A1
(en)
|
2022-03-07 |
2023-09-14 |
Mina Therapeutics Limited |
Il10 sarna compositions and methods of use
|
WO2023177904A1
(en)
|
2022-03-18 |
2023-09-21 |
Modernatx, Inc. |
Sterile filtration of lipid nanoparticles and filtration analysis thereof for biological applications
|
WO2023183909A2
(en)
|
2022-03-25 |
2023-09-28 |
Modernatx, Inc. |
Polynucleotides encoding fanconi anemia, complementation group proteins for the treatment of fanconi anemia
|
WO2023196399A1
(en)
|
2022-04-06 |
2023-10-12 |
Modernatx, Inc. |
Lipid nanoparticles and polynucleotides encoding argininosuccinate lyase for the treatment of argininosuccinic aciduria
|
WO2023215498A2
(en)
|
2022-05-05 |
2023-11-09 |
Modernatx, Inc. |
Compositions and methods for cd28 antagonism
|
WO2024026254A1
(en)
|
2022-07-26 |
2024-02-01 |
Modernatx, Inc. |
Engineered polynucleotides for temporal control of expression
|
WO2024044147A1
(en)
|
2022-08-23 |
2024-02-29 |
Modernatx, Inc. |
Methods for purification of ionizable lipids
|
WO2024097639A1
(en)
|
2022-10-31 |
2024-05-10 |
Modernatx, Inc. |
Hsa-binding antibodies and binding proteins and uses thereof
|
WO2024100046A1
(en)
|
2022-11-07 |
2024-05-16 |
Targimmune Therapeutics Ag |
Targeted linear conjugates comprising polyethyleneimine and polyethylene glycol and polyplexes comprising the same
|
WO2024100040A1
(en)
|
2022-11-07 |
2024-05-16 |
Targimmune Therapeutics Ag |
Psma-targeting linear conjugates comprising polyethyleneimine and polyethylene glycol and polyplexes comprising the same
|
WO2024100044A1
(en)
|
2022-11-07 |
2024-05-16 |
Targimmune Therapeutics Ag |
Polyplexes of nucleic acids and targeted conjugates comprising polyethyleneimine and polyethylene glycol
|
CN115844822B
(zh)
*
|
2022-11-23 |
2024-05-14 |
上海交通大学医学院附属第九人民医院 |
一种口服载药胶束组合物及其制备方法
|
WO2024118866A1
(en)
|
2022-12-01 |
2024-06-06 |
Modernatx, Inc. |
Gpc3-specific antibodies, binding domains, and related proteins and uses thereof
|
WO2024130158A1
(en)
|
2022-12-16 |
2024-06-20 |
Modernatx, Inc. |
Lipid nanoparticles and polynucleotides encoding extended serum half-life interleukin-22 for the treatment of metabolic disease
|